CAS 848259-27-8 appears in our catalog under these names: Pemafibrate, 95%, pemafibrate, 99%, Pemafibrate, pemafibrate 99%, (2R)-2-[3-[[1,3-benzoxazol-2-yl-[3-(4-methoxyphenoxy)propyl]amino]methyl]phenoxy]butanoic acid, 99%, 99%. Offered by: Combi-blocks, AmBeed, GLPBio, Biosynth, Chemat. Available pack sizes: 100mg, 1g, 250mg, 25mg, 10mg, 5mg, 10mM (in 1ml dmso), 50mg.
Pemafibrate is a member of the class of 1,3-benzoxazoles that is 1,3-benzoxazol-2-amine in which the amino hydrogens are replaced by 3-[(1R)-1-carboxypropoxy]benzyl and 3-(4-methoxyphenoxy)propyl groups. It is a selective peroxisome proliferator-activated receptor (PPAR)-alpha agonist that is used for the treatment of hyperlipidaemia. It has a role as an antilipemic drug, a hepatoprotective agent and a PPARalpha agonist. It is a monocarboxylic acid, an aromatic amine, a tertiary amino compound, a member of 1,3-benzoxazoles and a member of methoxybenzenes.
Source: ChEBI
| Molecular formula | C28H30N2O6 |
|---|---|
| Molecular weight | 490.5 g/mol |
| IUPAC name | (2R)-2-[3-[[1,3-benzoxazol-2-yl-[3-(4-methoxyphenoxy)propyl]amino]methyl]phenoxy]butanoic acid |
| InChIKey | ZHKNLJLMDFQVHJ-RUZDIDTESA-N |
| SMILES | CC[C@H](C(=O)O)OC1=CC=CC(=C1)CN(CCCOC2=CC=C(C=C2)OC)C3=NC4=CC=CC=C4O3 |
Computed by PubChem (NCBI)